Article
Cell trajectory modulation: rapid microfluidic biophysical profiling of CAR T cell functional phenotypes
22 May 2025
Abstract excerpt
Chimeric Antigen Receptor (CAR) T cell therapy is a pivotal treatment for hematological malignancies. However, CAR T cell products exhibit batch-to-batch variability in cell number, quality, and in vivo efficacy due to donor-to-donor heterogeneity, and pre/post-manufacturing processes, and the manufacturing of such products necessitates careful testing, both post-manufacturing and pre-infusion. Here, we introduce...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
